Efficacy and Safety of Covid-19 Vaccine in Cardiac Patients
- Conditions
- COVID-19 Vaccine
- Registration Number
- NCT05348629
- Lead Sponsor
- Mina sobhi said fam
- Brief Summary
Efficacy and safety of covid-19 vaccine in Cardiac patients
- Detailed Description
investigate the efficacy and safety of covid-19 vaccine in cardiac patients and its possible assocciated morbidity
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Subjects diagnosed as STEMI undergo PPCI as (Fourth universal definition of myocardial infarction (2018) Kristian Thygesen) 10
- with age range from 18 to 80 years after 1 month of STEMI .
Exclusion Criteria
- Patients with previous covid infection confirmed by swap or CT chest or ICU addmision.
- Patients with previous covid infection confirmed by qualitative antibdy test .
- Patients with history of anaphylaxis to any component of the vaccine should not take it .
- patients with febrile illness or acute , ongoing infection .
- immunosuppressive diseases .
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Myocardial infarction one year Myocardial infarction
stent thrombosis one year stent thrombosis
all cause mortality one year all cause mortality
- Secondary Outcome Measures
Name Time Method heart failure hospitalization one year heart failure hospitalization
anaphylaxis required hospitalization one year anaphylaxis required hospitalization
Cardiovascular death. Cardiovascular death. Cardiovascular death.Cardiovascular death. cardiovascular death one year Cardiovascular death.
infection by covid-19 one year infection by covid-19
Trial Locations
- Locations (2)
Assiut University
🇪🇬Assiut, Egypt
Assiut university
🇪🇬Assiut, Egypt